Glutamatergic autoencephalitides: An emerging field

Journal of Neural Transmission

Volumn 121, Issue 8, 2014, Pages 957-968

  Panzer, Jessica A ^a,b   Gleichman, Amy J ^c   Lynch, David R ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMPA receptors; Autoantibody; Autoimmune encephalitis; Glutamate receptors; NMDA receptors

Indexed keywords

ALPHA AMINO 3 HYDROZY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID RECEPTOR ANTIBODY; AMPA RECEPTOR; CYCLOPHOSPHAMIDE; EPITOPE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; NEUROTRANSMITTER RECEPTOR; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; GLUTAMIC ACID;

ALPHA AMINO 3 HYDROZY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; AMINO TERMINAL SEQUENCE; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CLINICAL MEDICINE; CONSCIOUSNESS DISORDER; DEMENTIA; ENCEPHALITIS; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; ISOLATED PSYCHOSIS; LEARNING; MEMORY; MOTOR DYSFUNCTION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; NEUROPSYCHIATRY; NONHUMAN; OVARY TERATOMA; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEIZURE; SYNAPSE; ANIMAL; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN DISEASES; HASHIMOTO DISEASE; METABOLISM;

ANIMALS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN DISEASES; GLUTAMIC ACID; HASHIMOTO DISEASE; HUMANS; RECEPTORS, AMPA;

EID: 84925695131     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1152-4     Document Type: Article

References (101)

1. Armangue T, Titulaer MJ, Má'laga I, Bataller L, Gabilondo I, Graus F, Dalmau J (2012) Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 162:850-856
2. Arundine M, Tymianski M (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657-668
3. Baldridge EB, Bensen HA (1990) Phencyclidine. Emerg Med Clin N Am 8:541-550
4. Bataller L, Galiano R, Garcia-Escrig M, Martinez M, Sevilla T, Vilchez J, Dalmau J (2010) Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 74:265-267
5. Belsham B (2001) Glutamate and its role in psychiatric illness. Hum Psychopharmacol 16:139-146
6. Bennett M (2009) Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust N Z J Psychiatry 43:711-721
7. Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622-1638
8. Bonham AC (1995) Neurotransmitters in the CNS control of breathing. Respir Physiol 101:219-230
9. Choe C-U, Karamatskos E, Schattling B, Leypoldt F, Liuzzi G, Gerloff C, Friese a M, Mulert C (2013) A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder. Psychiatry Res 208:194-196
10. Cook DR, Gleichman AJ, Cross SA, Doshi S, Ho W, Jordan-Sciutto KL, Lynch DR, Kolson DL (2011) NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem 118:1113-1123
11. Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25-36
12. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091-1098
13. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63-74
14. DeTiege X, Rozenberg F, Des Portes V, Lobut JB, Lebon P, Ponsot G, H B (2003) Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 61:241-243
15. Fan MMY, Raymond LA (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol 81:272-293
16. Farina AN, Blain KY, Maruo T, Kwiatkowski W, Choe S, Nakagawa T (2011) Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors. J Neurosci 31:3565-3579
17. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11-18
18. Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325-338
19. Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, Iwasaki Y, Yoshida M, Izumi Y, Kaji R (2012) Antibodies to Nmethyl- D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol 251:90-93
20. Furukawa H (2012) Structure and function of glutamate receptor amino terminal domains. J Physiol 590:63-72
21. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis 54:899-904
22. Ganor Y, Goldberg-Stern H, Lerman-Sagie T, Teichberg VI, Levite M (2005) Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/ AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. Epilepsy Res 65:11-22
23. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P (2009) Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459:703-707
24. Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR (2012) Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 32:11082-11094
25. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835-844
26. Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY (2001) Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124:1138-1148
27. Graus F, Boronat A, Xifró X, Boix M, Svigelji V, Garcia A, Palomino A, Sabater L, Alberch J, Saiz A (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 74:857-859
28. Hacohen Y, Deiva K, Pettingill P, Waters P, Siddiqui A, Chretien P, Menson E, Lin J-P, Tardieu M, Vincent A, Lim MJ (2013) Nmethyl- D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord [Epub ahead of print]
29. Hahn C-G, Wang H-Y, Cho D-S, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12:824-828
30. Hansen KB, Furukawa H, Traynelis SF (2010) Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol 78:535-549
31. Höftberger R, Armangue T, Leypoldt F, Graus F, Dalmau J (2013) Clinical neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-D aspartate receptor antibodies are part of the problem. Clin Neuropathol 32:251-254
32. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866-5875
33. Hutchinson M, Waters P, McHugh J (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71:1291-1292
34. Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45:583-595
35. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655-1667
36. ItoY,KimuraH,YabutaY,AndoY, Murakami T, ShiomiM,Morishima T (2000) Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 30:185-187
37. Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y, Gouaux E (2009) Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J 28:1812-1823
38. Joos AAB, Ziyeh S, Rauer S, Keller E, Huzly D, Lücking CH (2003) Postinfectious autoimmune-mediated encephalitis eight months after herpes simplex encephalitis. Eur Neurol 50:54-56
39. Karakas E, Simorowski N, Furukawa H (2009) Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28:3910-3920
40. Karakas E, Simorowski N, Furukawa H (2011) Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 475:249-253
41. Kashyape P, Taylor E, Ng J, Krishnakumar D, Kirkham F, Whitney A (2012) Successful treatment of two paediatric cases of anti- NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol 16:74-78
42. Kayser M, Dalmau J (2011) The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin 23:90-97
43. Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J (2013) Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 70:1133-1139
44. Keifer J, Zheng Z (2010) AMPA receptor trafficking and learning. Eur J Neurosci 32:269-277
45. Keime-Guibert F, Graus F, Fleury A, René R, Honnorat J, Broet P, Delattre JY (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479-482
46. Kessels HW, Malinow R (2009) Synaptic AMPA receptor plasticity and behavior. Neuron 61:340-350
47. Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morishima T (1992) Relapse of herpes simplex encephalitis in children. Pediatrics 89:891-894
48. Knafo S, Venero C, Sá'nchez-Puelles C, Pereda-Peréz I, Franco A, Sandi C, Suá'rez LM, Solís JM, Alonso-Nanclares L, Martín ED, Merino-Serrais P, Borcel E, Li S, Chen Y, Gonzalez-Soriano J, Berezin V, Bock E, Defelipe J, Esteban JA (2012) Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement. PLoS Biol 10:e1001262
49. Koike H, Tanaka F, Sobue G (2011) Paraneoplastic neuropathy: wideranging clinicopathological manifestations. Curr Opin Neurol 24:504-510
50. Kopec CD, Real E, Kessels HW, Malinow R (2007) GluR1 links structural and functional plasticity at excitatory synapses. J Neurosci 27:13706-13718
51. Koutsilieri E, Riederer P (2007) Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease. Parkinsonism Relat Disord 13(Suppl 3):S329-S331
52. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH (2007) NMDA receptors and schizophrenia. Curr Opin Pharmacol 7:48-55
53. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424-434
54. Lai M, Huijbers MGM, Lancaster E, Graus F, Bataller L, Balice- Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776-785
55. Lai TW, Shyu W-C, Wang YT (2011) Stroke intervention pathways: NMDA receptors and beyond. Trends Mol Med 17:266-275
56. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67-76
57. Lancaster E, Huijbers MGM, Bar V, Boronat A, Wong A, Martinez- Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J (2011a) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303-311
58. Lancaster E, Titulaer MJ, Boulos M, Weaver S, Liebers E, Kornblum C, Bien CG, Honnorat J, Wong S, Xu J, Contractor A, Dalmau J (2011b) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77:1698-1701
59. Li Q, Roberts AC, Glanzman DL (2005) Synaptic facilitation and behavioral dishabituation in Aplysia: dependence on release of Ca2? from postsynaptic intracellular stores, postsynaptic exocytosis, and modulation of postsynaptic AMPA receptor efficacy. J Neurosci 25:5623-5637
60. Lindstrom J (2002) Autoimmune diseases involving nicotinic receptors. J Neurobiol 53:656-665
61. Lynch MA (2004) Long-term potentiation and memory. Phsyiol Rev 84:87-136
62. Makino H, Malinow R (2009) AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis. Neuron 64:381-390
63. Mangler M, Trebesch de Perez I, Teegen B, Stöcker W, Prüss H, Meisel A, Schneider A, Vasiljeva J, Speiser D (2013) Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma. J Neurol 260:2831-2835
64. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J (2011) Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 77:589-593
65. Masdeu J, Gonzalez-Pinto A, Matute C, Ruiz de Azua S, Palomino A (2012) Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in Schizophrenia. Am J Psychiatry 169:1120-1121
66. Meddows E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P, McIlhinney RA (2001) Identification of molecular determinants that are important in the assembly of N-methyl-Daspartate receptors. J Biol Chem 276:18795-18803
67. Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, Meissirel C, Honnorat J, Groc L (2012) Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 135:1606-1621
68. Miyamoto E (2006) Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci 100:433-442
69. Mohn AR, Gainetdinov RR, Caron MG, Koller BH, Hill C, Carolina N, Hughes H (1999) Mice with reduced NMDA receptor expression display behaviors related to Schizophrenia University of North Carolina at Chapel Hill. 98:427-436
70. Molinuevo JL, Graus F, Serrano C, Reñe R, Guerrero A, Illa I (1998) Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 44:976-980
71. Olney JWFN (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
72. Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33:1351-1365
73. Plant K, Pelkey KA, Bortolotto ZA, Morita D, Terashima A, McBain CJ, Collingridge GL, Isaac JTR (2006) Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci 9:602-604
74. Prüss H, Finke C, Höltje M, Hofmann J, Klingbeil C, Probst C, Borowski K, Ahnert-Hilger G, Harms L, Schwab JM, Ploner CJ, Komorowski L, Stoecker W, Dalmau J, Wandinger KP (2012a) Nmethyl- D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902-911
75. Prüss H, Höltje M, Maier N, Gomez A, Buchert R, Harms L, Ahnert- Hilger G, Schmitz D, Terborg C, Kopp U, Klingbeil C, Probst C, Kohler S, Schwab JM, Stoecker W, Dalmau J, Wandinger KP (2012b) IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 78:1743-1753
76. Rhoads J, Guirgis H, McKnight C, Duchemin AM (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophr Res 129:213-214
77. Robbins TW, Murphy ER (2006) Behavioural pharmacology: 40 ? years of progress, with a focus on glutamate receptors and cognition. Trends Pharmacol Sci 27:141-148
78. Robillard JM, Gordon GR, Choi HB, Christie BR, MacVicar BA (2011) Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult. PLoS ONE 6:e20676
79. Robinson NE, Robinson ZW, Robinson BR, Robinson AL, Robinson JA, Robinson ML, Robinson AB (2004) Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res 63:426-436
80. Sköldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, Andersson B, Linde A, Strannegård O, Studahl M, Hagberg L, Rosengren L (2006) Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 253:163-170
81. Slipczuk L, Bekinschtein P, Katche C, Cammarota M, Izquierdo I, Medina JH (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 4:e6007
82. Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH (2011) N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus. Arch Neurol 68:1069-1072
83. Sobolevsky AI, Rosconi MP, Gouaux E (2009) X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462:745-756
84. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein H-G, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 70:271-278
85. Takahashi Y, Mori H, Mishina M, Watanabe M, Kondo N, Shimomura J, Kubota Y, Matsuda K, Fukushima K, Shiroma N, Akasaka N, Nishida H, Imamura A, Watanabe H, Ikezawa M, Fujiwara T (2005) Autoantibodies and cell-mediated autoimmunity to NMDA-type GluR e 2 in patients with Rasmussen' s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia 46:152-158
86. Titulaer MJ, Lang B, Verschuuren JJ (2011) Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10:1098-1107
87. Titulaer MJ, Kayser MS, Dalmau J (2013a) Authors' reply. Lancet Neurol 12:425-426
88. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez- Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013b) Treatment and prognostic factors for longterm outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157-165
89. Traynelis SF, Wollmuth LP, Mcbain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels : structure, regulation, and function. Pharmacol Rev 62:405-496
90. Tsien J (2000) Linking Hebb's coincidence-detection to memory formation. Curr Opin Neurobiol 10:266-273
91. Tsutsui K, Kanbayashi T, Tanaka K, Boku S, Ito W, Tokunaga J, Mori A, Hishikawa Y, Shimizu T, Nishino S (2012) Anti- NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 12:37
92. Twyman RE, Gahring LC, Spiess J, Rogers SW (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14:755-762
93. Ulusoy C, Tüzün E, Kürtüncü M, Türkoğlu R, Akman-Demir G, Eraksoy M (2012) Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders. Int J Neurosci 122:284-289
94. Wang H, Hu Y, Tsien JZ (2006) Molecular and systems mechanisms of memory consolidation and storage. Prog Neurobiol 79:123-135
95. Waters KA, Machaalani R (2005) Role of NMDA receptors in development of respiratory control. Respir Physiol Neurobiol 149:123-130
96. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart Y, Palace J, Beeson D, Vincent A, Lang B (2004) Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63:43-50
97. Whitlock JR, Heynen AJ, Shuler MG, Bear MF (2006) Learning induces long-term potentiation in the hippocampus. Science 313:1093-1097
98. Wood PL, Hawkinson JE (1997) N-methyl-D-aspartate antagonists for stroke and head trauma. Expert Opin Investig Drugs 6:389-397
99. Yuan H, Hansen KB, Vance KM, Ogden KK, Traynelis SF (2009) Control of NMDA receptor function by the NR2 subunit aminoterminal domain. J Neurosci 29:12045-12058
100. Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258:686-688
101. Zhang Q, Tanaka K, Sun P, Nakata M, Yamamoto R, Sakimura K, Matsui M, Kato N (2012) Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 45:610-615